2005
DOI: 10.1021/jm049067d
|View full text |Cite
|
Sign up to set email alerts
|

Analogues of Thiolactomycin as Potential Antimalarial Agents

Abstract: Analogues of the natural antibiotic thiolactomycin (TLM), an inhibitor of the condensing reactions of type II fatty acid synthase, were synthesized and evaluated for their ability to inhibit the growth of the malaria parasite Plasmodium falciparum. Alkylation of the C4 hydroxyl group led to the most significant increase in growth inhibition (over a 100-fold increase in activity compared to TLM). To investigate the mode of action, the P. falciparum KASIII enzyme was produced for inhibitor assay. A number of TLM… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
68
1
3

Year Published

2006
2006
2017
2017

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 102 publications
(73 citation statements)
references
References 34 publications
1
68
1
3
Order By: Relevance
“…A greater understanding of this metabolic crossroad in BSFs may facilitate the discovery of drugs to treat African sleeping sickness. Recently, research on the structures of type II enzymes (62) has renewed interest in designing more selective drugs against previously validated FAS targets (63,64). Trypanosomes, however, may turn out to be more susceptible to new classes of natural product-based inhibitors of type II FAS (65,66).…”
Section: Discussionmentioning
confidence: 99%
“…A greater understanding of this metabolic crossroad in BSFs may facilitate the discovery of drugs to treat African sleeping sickness. Recently, research on the structures of type II enzymes (62) has renewed interest in designing more selective drugs against previously validated FAS targets (63,64). Trypanosomes, however, may turn out to be more susceptible to new classes of natural product-based inhibitors of type II FAS (65,66).…”
Section: Discussionmentioning
confidence: 99%
“…29 TLM exhibits moderate in vitro and potent in vivo activity against many pathogens such as Gram-positive and Gram-negative bacteria 30 including Mycobacterium tuberculosis 31 and malaria parasites. 32 TLM inhibits the type II cell wall fatty acid synthesis (FAS II) in bacteria and plants, 33 which explains the antibacterial and antiparasitical properties of TLM. Because TLM is not toxic in mammals, 30 over 100 synthetic, mainly nonpolar TLM congeners have been investigated to establish structure activity relationships (SAR) and molecular mechanisms of action of drug candidates with the common TA ring system.…”
Section: ■ Experimental Sectionmentioning
confidence: 99%
“…Experimental details for assays of the growth inhibition of Leishmania donovani axenic amastigotes have been reported previously (15). Amastigotes of Leishmania donovani strain MHOM/ET/67/L82 were grown in axenic culture at 37°C in synthetic minimal medium (12), at pH 5.4, supplemented with 10% heat-inactivated fetal bovine serum under an atmosphere of 5% CO 2 in air.…”
Section: Preparation Of Compoundsmentioning
confidence: 99%